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Research ArticleStimulation of hepatocarcinogenesis by neutrophils upon
induction of oncogenic kras expression in transgenic zebraﬁsh
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1Department of Biological Sciences, National University of Singapore, Singapore; 2National University of Singapore Graduate School for
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Research Institute, University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UKBackground & Aims: Chronic inﬂammation is a major etiological
factor for hepatocellular carcinoma (HCC), but how immune cells
respond in the initiation of hepatocarcinogenesis remains
uncharacterized. This study aims to investigate the response
and roles of neutrophils in early hepatocarcinogenesis.
Methods: By inducible expression of oncogenic krasV12 in hepato-
cytes in transgenic zebraﬁsh combined with live imaging of neu-
trophils in transparent larvae, the response of neutrophils to
oncogenic liver was characterized and their roles investigated
by pharmaceutical and genetic manipulations.
Results:We found a rapid recruitment of neutrophils to the liver
upon induction of krasV12 expression. Pharmaceutical stimulation
of neutrophils resulted in further increases of neutrophils in
oncogenic livers, liver size and tumor severity, while inhibition
of neutrophils caused decreases of liver-associated neutrophils
and liver size. Time-lapse video indicated that neutrophils had
a stagnant migratory pattern meandering along the tumor edge
but became relatively stationary upon entering the
krasV12-expressing liver. Both oncogenic hepatocytes and
tumor-associated neutrophils (TANs) were isolated via
ﬂuorescence-activated cell sorting. Molecular analyses indicated
a pro-inﬂammatory microenvironment, as marked by increased
tgfb1a expression in krasV12-expressing hepatocytes and a loss
of anti-tumor activities in TANs. Depletion of Tgf-b signiﬁcantly
reduced the number of TANs and the size of oncogenic liver.
Conclusions: An inﬂammatory cue from oncogenic hepatocytes
upon induction of krasV12 expression causes a rapid recruitment
of neutrophils to oncogenic liver and the neutrophils play a pro-
moting role in early hepatocarcinogenesis.Journal of Hepatology 20
Keywords: Liver; Tumor-associated neutrophil (TAN); Inﬂammation; Tgf-b;
Tumor initiation.
Received 22 September 2014; received in revised form 13 March 2015; accepted 19
March 2015; available online 28 March 2015
⇑ Corresponding author. Address: Department of Biological Sciences, National
University of Singapore, Singapore. Tel.: +65 65162860; fax: +65 67792486.
E-mail address: dbsgzy@nus.edu.sg (Z. Gong).
 These authors contributed equally.
Abbreviations: HCC, hepatocellular carcinoma; FACS, ﬂuorescence-activated cell
sorting; Gcsfr, Granulocyte colony-stimulating factor receptor; TAN,
tumor-associated neutrophil; NN, naïve neutrophil; RT-qPCR, reverse
transcription-quantitative PCR; LPS, lipopolysaccharide; dpf, day post
fertilization; H&E, hematoxylin and eosin; TUNEL, terminal deoxynucleotidyl
transferase dUTP nick end labeling. 2015 European Association for the Study of the Liver. Published
by Elsevier B.V. All rights reserved.Introduction
In the past decade, increasing evidence has indicated a dual role of
neutrophils in a variety of tumors [1]. On one hand, activated neu-
trophils are capable of killing tumor cells through oxidative bursts
[2] and secretion of anti-tumor cytokines such as TNF-a and IFNs
[3]. On the other hand, in certain situations, neutrophils have also
been found to promote tumor progression. Tumor-associated neu-
trophils (TANs) have long been observed to correlate to tumor pro-
gression in chronic colitis-associated carcinogenesis or gastric
adenocarcinoma [4–6]. These alternatively behaved neutrophils
are capable of releasing growth-stimulating signals,
matrix-degrading proteases, and angiogenesis mediators [1,7],
favoring tumorprogression.Recently, it hasbeen reported theexis-
tence of subtypes N1 (anti-tumoral) and N2 (pro-tumoral) neu-
trophils; the neutrophil plasticity appears to be regulated by
transforming growth factor-beta (Tgf-b), which is often found to
be secreted by cancer cells [4]. Neutrophils are induced by Tgf-b
to acquire anN2phenotype,whichdiffers fromN1neutrophils that
require inhibition of Tgf-b and sufﬁcient ifn-b [4,8].
The inﬂuence between neutrophils and cancer cells are recip-
rocal. While tumor cells are capable of hyper-expressing
pro-inﬂammatory molecules, mimicking the initial phase of
wound healing [9], to attract neutrophils to the localized tumor
microenvironment [10], the inﬁltrating neutrophils also have
pro-angiogenic effects and promotes epithelial to mesenchymal
transition during tumor progression [11,12]. This integral rela-
tionship between immune cells and tumor cells is particularly
evident in HCC, which is a typical inﬂammation-associated can-
cer since the primary etiological factors, hepatitis B and C viruses,
create an unresolved, chronic inﬂammation of the liver [13]. To
date, systemic therapy has not been effective in HCC patients
[14,15], although targeted therapy with a multi-kinase inhibitor,
sorefenib, has limited efﬁcacy in several clinical trials [16,17].
Thus, immune-based therapy could be a new promising approach
for HCC patients. The study of the interaction between HCC and
neutrophils should provide much needed insights into the devel-
opment of such a therapeutic approach.15 vol. 63 j 420–428
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Recently we have generated several inducible HCC models
by transgenic expression of an oncogene in zebraﬁsh hepato-
cytes [18–21]. A major advantage of these inducible models is
the temporal control of cancer initiation to provide an excellent
opportunity to characterize tumor initiation events, hitherto
lacking in human clinical studies and other non-inducible
tumor models. Furthermore, the transparency of zebraﬁsh lar-
vae allows us to monitor early in vivo hepatocarcinogenesis
and progression, thus providing a plethora of opportunities to
investigate the initiation events in hepatocarcinogenesis and
the roles of various cancer hallmark factors in the process. In
particular, we recently observed a prominent immune response
in HCC progression and regression in one of our zebraﬁsh HCC
models based on RNA-Seq analyses [22]. In the present study,
the interaction of neutrophils and oncogenic hepatocytes in
hepatocarcinogenesis was investigated. We observed a rapid
recruitment of neutrophils into oncogenic liver, which led to
accelerated tumor progression. Molecular analyses of
ﬂuorescence-activated cell sorting (FACS)-isolated hepatocytes
and TANs indicated changes of several important molecular
pathways, including promotion of a pro-inﬂammatory microen-
vironment in oncogenic hepatocytes and decreases of
anti-tumor in TANs. Thus, our data suggest a promoting role
of neutrophils in early hepatocarcinogenesis.Materials and methods
Zebraﬁsh husbandry
Zebraﬁsh were maintained in compliance with Institutional Animal Care and Use
Committee guidelines, National University of Singapore. Four transgenic lines,
Tg(fabp10:rtTA2s-M2; TRE2:EGFP-krasG12V) in a Tet-On system for inducible
liver-speciﬁc expression of oncogenic krasG12V [18], Tg(lyz:DsRed2)nz50 with
DsRed-labeled neutrophils under the lysozyme C (lyz) promoter [23],
Tg(fabp10a:DsRed; ela3l:GFP)gz15 with DsRed-labeled liver and GFP-labeled exo-
crine pancreas [24], Tg(mpeg1:GFP)gl22, with GFP-labeled macrophages under
thempeg1 promoter [25], were used and referred to as kras, lyz, fabp10, andmpeg,
respectively, in the present report.
Chemical treatment
20 lg/ml doxycycline (Sigma, D9891) was added from 3 days post-fertilization
(dpf) to 8 dpf to induce krasG12V-EGFP expression. Lipopolysaccharides (LPS)
(Sigma, L4391), FPR-A14 (Tocris, 2826), PR-39 (Tocris, 1947) and SB431542
(Tocris, 1614) were ﬁrst dissolved in dimethyl sulfoxide as stocks and used
for larva exposure at 5 ng/ml, 2.5 lM, 50 nM and 2.5 lM respectively from 4
to 8 dpf. The dosages were selected based on the highest all-survival
concentrations.
Statistical analysis
Statistical signiﬁcance between two groups was evaluated by two-tailed unpaired
Student t test using inStat version 5.0 for Windows (GraphPad, San Diego, CA).
Statistical data are presented as mean value ± standard error of mean (SEM).
Throughout the text, ﬁgures, and ﬁgure legends, the following terminology is
used to denote statistical signiﬁcance: *p <0.05, **p <0.01, ***p <0.001.
Other methods
Other methods are described in Supplementary Materials and methods, including
morpholino knockdown and Tgf-b depletion; photography and image analysis;
isolation of hepatocytes and neutrophils by FACS; RNA extraction, cDNA ampliﬁ-
cation and RT-qPCR (reverse transcription-quantitative PCR); and histological and
cytological analyses.Journal of Hepatology 201Results
Rapid recruitment of neutrophils into krasV12-expressing livers
To visualize the inﬂammation response, hemizygous kras+ trans-
genic ﬁsh were crossed with lyz+ homozygous ﬁsh for production
of kras+ and kras offspring in the lyz+ background, DsRed
expressing neutrophils were monitored up to 96 hpi (hour
post-induction with doxycycline). As shown in Fig. 1A and quan-
tiﬁed in Fig. 1B–D, the total counts of neutrophils in the liver
region was noticeably increased from as early as 8 hpi and
became statistically signiﬁcant from 16 hpi (Fig. 1B). These neu-
trophils within the vicinity of the liver, considered as TANs, were
normalized against the liver size as neutrophil density. As shown
in Fig. 1C, a signiﬁcant increase in neutrophil density was
observed from 8 hpi; thus, neutrophils were actively recruited
to the site of tumor initiation within 8 hours of oncogene activa-
tion. In contrast, the increase of liver size became apparent only
from 24 hpi (Fig. 1D), indicating that neutrophil recruitment pre-
ceded liver enlargement. To further evaluate the contribution of
neutrophils to the increased liver size in kras+ larvae, neutrophil
density and liver size were plotted for each individual kras+ larva
and we observed a strong positive correlation (Pearson’s coefﬁ-
cient, 0.62); in contrast, such a correlation was not present in
kras siblings (Pearson’s coefﬁcient, 0.20) (Fig. 1E).
Acceleration of hepatocarcinogenesis by stimulation of general
immune response and neutrophils
To further demonstrate the role of inﬂammatory cells in initia-
tion and progression of hapatocarcinogenesis, we ﬁrst tested a
general inﬂammatory stimulator, LPS, which has been demon-
strated to stimulate the immune system in zebraﬁsh larvae
[26]. 5 ng/ml of LPS was used to treat zebraﬁsh larvae from
4 dpf to 8 dpf. kras+ larvae exposed to both LPS and doxycycline
showed signiﬁcant increases of both neutrophil count and den-
sity in the liver as compared to kras+ larvae exposed to doxycy-
cline alone and all kras groups. Interestingly, there was also a
further enlargement of liver size with the increased neutrophils
(Fig. 2A). To investigate if the accelerated liver enlargement
was indeed associated with increased neutrophil inﬁltration,
FPR-A14, which is a formyl peptide receptor agonist and has been
reported to potently activate neutrophils speciﬁcally in vitro [27],
was used to challenge the kras+ larvae from 4 dpf to 8 dpf. Liver
neutrophil count and density in FPR-A14 and doxycycline
double-treated kras+ larvae were also signiﬁcantly higher than
those of their kras+ sibling treated with only doxycycline and of
all kras groups (Fig. 2B), similar to that observed following
LPS treatment. A further liver enlargement was also observed
from these double-treated kras+ larvae. To further demonstrate
the effect of neutrophils, kras+ transgenic larvae were also chal-
lenged with a neutrophil inhibitor, PR-39, a proline-rich
anti-bacteria peptide that inhibits NADPH oxidase activity in
neutrophils [28]. As shown in Fig. 2C, liver neutrophil count
and density as well as liver size in kras+ larvae exposed to
PR-39 and doxycycline were all decreased as compared to kras+
sibling controls treated with doxycycline alone and all kras
groups. Thus, there was a good correlation between numbers of
inﬁltrated neutrophils and the size of oncogenic liver, suggesting
an in vivo promoting role of neutrophils in early
hepatocarcinogenesis.5 vol. 63 j 420–428 421
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Fig 1. Recruitment of neutrophils to oncogenic liver. (A) Representative images of kras/lyz+ and kras+/lyz+ larvae after 8, 24, and 96 hours of doxycycline induction
starting from 3 dpf. The livers are outlined in blue dash lines in the upper images of kras/lyz+ larvae and marked by GFP expression in the lower images of kras+/lyz+ larvae.
(B–D) Time course of neutrophil count (B), neutrophil density (C) and liver size (D) following induction of oncogenic krasV12 expression in hepatocytes (n >15 from each
group). Neutrophils were counted in the liver area and normalized against the liver size for liver density. Liver size was measured based on 2D images. (E) Correlation of
liver size and neutrophil density in the liver. The measurements were based on 8 dpf larvae after 5 days of doxycycline induction. A positive correlation was observed only
in the kras+ transgenic larvae (top) but not in the kras control group (bottom). Statistical signiﬁcance: *p <0.05, **p <0.01, ***p <0.001.
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Fig. 2. Effect of inﬁltrated neutrophils on liver size. (A–C) Neutrophil counts
(left) and density (middle) in the liver area and liver size (right) in response to
treatments of LSP (A), FPR A14 (B) or PR39 (C). Both kras/lyz+ and kras+/lyz+
groups were similarly exposed to doxycycline from 3 dpf and neutrophils
mediators were added from 4 dpf. Neutrophils and liver sizes were determined
at 8 dpf (n >15 from each group). Statistical signiﬁcance: *p <0.05.
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422 Journal of Hepatology 201Inhibition of neutrophil differentiation defers HCC progression
To further validate the effect of neutrophils on tumor growth, dif-
ferentiation of myeloid derived precursor cells into neutrophils
was blocked via morpholino knockdown of the gcsfr gene
(MO_gcsfr). MO_gcsfr or control morpholino (MO_SC) were
injected into lyz+ embryos at one-cell stage and injected embryos
were monitored for DsRed+ neutrophils. As shown in
Supplementary Fig. 1A and C, by 6 dpf, there was an overall
decrease of circulating neutrophils in MO_gscfr injected larvae,
compared to those in lyz+ larvae injected with MO_SC, consistent
with the previous report that used the same set of morpholinos
[29]. kras+/lyz+ and kras/lyz+ zebraﬁsh embryos were then
injected with MO_gscfr and analysed at 6 dpf after doxycycline
induction from 3 dpf. Similar to the observations with the
PR-39 inhibitor, a signiﬁcant decrease of neutrophil counts and
density in the liver (Fig. 3D and E) as well as liver size (Fig. 3F)
was observed, further conﬁrming a promoting role of neutrophils
in the initial stage of hepatocarcinogenesis.
To evaluate the role of macrophages in our model, depletion of
macrophages was carried out by morpholino knockdown of the
irf8 gene [25]. As shown in Supplementary Fig. 1B and C, when
mpeg+ embryos were injected with MO_irf8, GFP expressing
macrophages were greatly reduced; meanwhile, there was a
compensating increase of neutrophils, consistent with a previous
report that knockdown of irf8 causes the common progenitor
cells to differentiate to neutrophils [25]. When MO_irf8 was
injected into kras+/lyz+ embryos, we observed a signiﬁ-
cant increase of neutrophil counts and density in the liver5 vol. 63 j 420–428
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JOURNAL OF HEPATOLOGY(Fig. 3C–E) with a corresponding increase of liver size (Fig. 3F).
While the depletion of macrophages may not be conclusive for
establishing their role in early hepatocarcinogenesis, it did
demonstrate that neutrophils alone retained tumor prompting
activity.
Stagnant migratory pattern of tumor inﬁltrate neutrophils
Neutrophil migratory pattern was also examined using confocal
time-lapse video and resulting in an obvious difference in neu-
trophil movement between kras+ and kras larvae in the pres-
ence of doxycycline. In a 1-hour time-lapse video of 8 dpf kras+
larvae (Supplementary Video 1), neutrophils had active migratory
movement surrounding the liver. However, within the liver, inﬁl-
trated neutrophils were rather stationary with only minimal
movement. In kras siblings (Supplementary Video 2), in con-
trast, neutrophils were uniformly active both within and outside
the liver. The difference was further illustrated by tracking neu-
trophil movement from these videos using the Imaris softwareJournal of Hepatology 201(Fig. 4A and B). Thus, the tumor microenvironment leads to an
inactive migratory behavior of inﬁltrated neutrophils.
Increase of segmented nuclei of TANs
It has been reported that TANs in rodent models have distinct
nuclear morphology with a high percentage of segmented nuclei
[4]. To examine whether our isolated TANs also displayed similar
nuclear morphology, Giemsa staining on FACS-isolated neu-
trophils was performed. The neutrophil nuclei were characterized
into three broad categories according to Fridlender et al. [4]: i)
round nuclei denoting a naive status; ii) bi-lobed structure repre-
senting fully differentiated and mature neutrophils; iii)
hyper-segmented nuclei frequently associated with tumors
(Fig. 4C). In both kras and kras+ transgenic zebraﬁsh, round
nuclei represented 20-30% of the isolated neutrophils. In kras
larvae, the remaining neutrophils had bi-lobed nuclei (75%) and
only a very small percentage (3%) had hyper-segmented nuclei
(Fig. 4D). However, in kras+ larvae, hyper-segmented nuclei neu-
trophils made up of 43% of total neutrophil population (Fig. 4D),
suggesting that our isolated neutrophils from the
doxycycline-induced kras+ larvae were indeed enriched with
TANs.
Promotion of proliferation and suppression of apoptosis in
krasG12V-expressing hepatocytes by inﬁltrated neutrophils
To identify the causative factors for liver size change when neu-
trophil activity was modulated, hepatocyte proliferation and
apoptosis were examined. As shown in Fig. 5, there were signiﬁ-
cant increases of hepatocyte proliferation and apoptosis in
doxycycline-induced kras+ larvae, suggesting highly aberrant cell
division and death in oncogenic livers. While co-exposure to5 vol. 63 j 420–428 423
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Research ArticleFPR-A14/doxycycline did not induce a further increase of prolifer-
ating hepatocytes, it did lead to a signiﬁcant reduction of apop-
totic hepatocytes. In contrast, co-treatment of kras+ larvae with
PR-39/doxycycline reduced the number of proliferating hepato-
cytes and increased the number of apoptotic hepatocytes. Thus,
the changes in neutrophil activity affect both proliferation and
apoptosis of hepatocytes.424 Journal of Hepatology 201Moderated histological phenotype of oncogenic hepatocytes by
inhibition of neutrophil activity
Histologically, as shown in Fig. 6A, all H&E staining of 8 dpf kras+
larvae exposed to doxycycline showed histological features of
early carcinoma, e.g. disorganized cell plate, large
nucleus-to-cytoplasm ratio and pseudo glandular patterns. All
kras+ larvae exposed to FPR-A14 and doxycycline showed similar
early carcinoma histology, but with signiﬁcantly less proportion
of normal tissue, suggesting that the additional exposure to
FPR-A14 had further stimulated HCC progression. In contrast,
most kras+ larvae exposed to PR-39 and doxycycline did not dis-
play the early carcinoma phenotype and instead resembles clo-
sely to the liver phenotype of control kras larvae, implying
exposure to PR-39 deters progression into HCC. Fig. 6B summa-
rizes the quantitative distribution of histological phenotypes in
each treatment group, further indicating that inhibition of neu-
trophils led to moderated tumor phenotype while activation of
neutrophils deteriorated the phenotype. The liver phenotype
was also examined by immunostaining using two ﬁbrosis mark-
ers, Laminin and Collagen 1a [30] (Supplementary Fig. 2) and we
observed increases of both biomarkers in induced kras+ onco-
genic livers, which were further increased by FPR-A14 but atten-
uated by PR-39, consistent with the general trends of liver tumor
severity based on H&E staining.
Pro-inﬂammatory microenvironment of oncogenic liver and reduction
of anti-tumor activities of TANs
It has been well established that cancer cells are capable of cre-
ating a pro-inﬂammatory microenvironment [31,32]. To investi-
gate molecular interaction of oncogenic hepatocytes and5 vol. 63 j 420–428
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JOURNAL OF HEPATOLOGYneutrophils in our model, GFP-krasG12V-expressing hepatocytes
were isolated from doxycycline-treated kras+ larvae by FACS
and meanwhile enriched TANs were isolated based on DsRed
expression (Fig. 7A). RT-qPCR analysis of kras+ hepatocytes
(Fig. 7B) showed a signiﬁcant upregulation of tgfb1a, a primary
regulator in early development of liver ﬁbrosis and
cancer-related inﬂammation [33,34]. In contrast, key anti-tumor
genes such as tnfa and ifnc showed signiﬁcant downregulation.
Meanwhile, compared to NNs, TANs showed a general
pro-tumor gene expression pattern. For instance, il1b, which pro-
motes early cancer angiogenesis [35], was signiﬁcantly upregu-
lated while anti-tumor cytokines, il4, il6, il8, il10, il12, and tnfa,
all showed signiﬁcant downregulation (Fig. 7C). Tgf-b is known
to polarize neutrophils to a pro-tumor phenotype [4]. To investi-
gate if oncogenic hepatocyte-secreted Tgf-b mediated crosstalk
between the two cell types, SB431542, a speciﬁc inhibitor of
Tgf-b type I receptor [36,37], was used to block Tgf-b signaling
in TANs where both tgfbr1a and tgfbr1b were found to be
expressed (data not shown). Compared to unblocked TANs,Journal of Hepatology 201signiﬁcant upregulation of all but one examined anti-tumor
cytokines (il6, il8, il10, il12, and tnfa) was observed in Tgf-b recep-
tor blocked TANs. Thus, blockage of Tgf-b signaling partially res-
cued the expression of these anti-tumor genes (Fig. 7D).
Since Tgf-b has been reported to be a chemoattractant for
neutrophils [38], we further depleted Tgf-b by injection of zebra-
ﬁsh Tgf-b antibody into 3 dpf kras+/lyz+ zebraﬁsh as well as by
SB431542 inhibition of TGF-b receptor [39]. We noticed reduced
neutrophils in the liver by 8 dpf by both approaches
(Fig. 8A and C) as conﬁrmed by the decreases in neutrophil
counts and density in the liver, which was also accompanied with
a decrease in liver size (Fig. 8B and D). The successful depletion of
Tgf-b was supported by signiﬁcant reductions of phosphorylated
Smad2, a downstream marker of the Tgf-b pathway in both neu-
trophils and hepatocytes (Fig. 8E–F). Collectively, these experi-
ments demonstrate the role of Tgf-b in attracting neutrophils to
the liver upon oncogenic kras activation in hepatocytes.Discussion
Rapid response of neutrophils to a pro-inﬂammatory microen-
vironment created by oncogenic krasV12-expressing hepatocytes
The chronic, unresolved inﬂammation is well recognized as one
of the hallmarks and a contributing factor of early HCC.
Persistent inﬂammation of the liver drives hepatocyte apoptosis
and compensatory proliferation, while prolonged abnormal
regeneration potentially promotes hepatic damage, ﬁbrosis, cir-
rhosis and eventually HCC [40]. TGF-b plays a crucial role in the
progression of the liver disease as the initial damage of liver
upregulates TGF-b to lead to a wound healing response [41]. In
our krasV12 transgenic model, krasG12V-expressing hepatocytes
displayed an upregulation of tgfb1a and downregulation of
anti-tumor genes, tnfa and ifnc. The gene expression pattern indi-
cated that the oncogenic kras+ hepatocytes favored a
pro-inﬂammatory environment, consistent with a previous
report of liver tumors arising from inﬂammation due to chronic
injury [42]. Moreover, decreased expression of tnfa and ifnc aids
in the creation of a pro-tumor microenvironment, which is in line
with clinical HCC data [43,44]. Thus, oncogenic krasV12 expression
have created a pro-inﬂammatory microenvironment in the HCC
initiation stage of HCC and downregulation of important
anti-tumor genes further facilitates the disease progression.
Moreover, TAN showed signiﬁcant downregulation of a variety
of anti-tumor cytokines, including il4, il6, il8, il10, il12, and tnfa,
and upregulation of pro-tumor il1b. These observations indicate
a crosstalk between the oncogenic hepatocytes and neutrophils.
Oncogenic hepatocytes secrete high level of Tgf-b which recruit
neutrophils as it has been demonstrated to be a potent chemoat-
tractant of neutrophils [38]. We further validated that depletion
of Tgf-b resulted in a signiﬁcant reduction of neutrophil density
in the oncogenic livers, which caused a decrease of oncogenic
liver size compared to oncogenic liver without Tgf-b depletion
(Fig. 8D). However, the liver size remained signiﬁcantly larger
than the size of livers in kras controls, which may indicate mul-
tiple roles of Tgf-b, including a suppressor in early tumor progres-
sion [45]. Once the neutrophils are recruited, a high level of Tgf-b
in oncogenic hepatocytes further causes TANs to reduce expres-
sion of anti-tumor genes and increase in il1b. Increased expres-
sion of il1b in TANs hints the possible angiogenesis promoting5 vol. 63 j 420–428 425
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Research Articlerole of TAN in HCC. Blockade of the Tgf-b signaling pathway by
SB431542 led to a partial rescue of the pro-tumor gene expres-
sion proﬁle in TAN, further validating the molecular crosstalk
between the two cell types.
Acceleration of HCC progression by TANs
Our data indicated a good correlation between the number/den-
sity of liver-inﬁltrated neutrophils and the size of oncogenic liver;
thus, it is likely that neutrophils play a stimulating role in liver
tumor initiation and progression. This phenomenon has been fur-
ther conﬁrmed by pharmacological experiments. Both the426 Journal of Hepatology 201general immune stimulator LPS and neutrophil-speciﬁc activator
FRP-A14 caused further increase of liver-inﬁltrated neutrophils
and also further increase of the liver size. Conversely, neutrophil
inhibitor, PR-39, caused a reduction of liver-inﬁltrated neu-
trophils and also slowed down the growth of oncogenic liver.
The observed effects by FRP-A14 and PR-39 appear to be mainly
due to the change of neutrophil numbers in the liver as neither
chemical affects the number of macrophages in the liver
(Supplementary Fig. 3). In addition, using Irf8 morpholino to
deplete macrophages and thus increase neutrophil density, we
demonstrated that neutrophil alone also have a signiﬁcant effect
in accelerating HCC progression.5 vol. 63 j 420–428
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Histologically, the severity of oncogenic livers also correlated
to the activity of neutrophils. There was a rapid oncogenic trans-
formation of hepatocytes upon krasG12V induction and histologi-
cal HCC phenotype could be observed within four days of
doxycycline induction. Neutrophils likely play an important role
in this process as inhibition of neutrophils by PR-39 resulted in
a liver histology close to a normal liver. The possible explanation
of the neutrophil-accelerated tumorigenesis lies in the ability of
neutrophils to induce proliferation and inhibit apoptosis in onco-
genic hepatocytes. Enhancement of the neutrophil activity using
an activator showed no further increase in hepatocyte prolifera-
tion but signiﬁcant inhibition of apoptosis. In contrast, inhibition
of neutrophil activity with PR-39 led to inhibition of proliferation
and promotion of apoptosis in hepatocytes (Fig. 5B and D).
Characteristic and behavior changes of neutrophils in tumor
microenvironment
It has been well documented that neutrophils are a heteroge-
neous population and the characteristic and behavior of TANs
and non-inﬁltrated neutrophils are markedly different [4]. In
our study, we also noticed several major differences between
TANs from oncogenic kras+ larvae and NNs from kras control
larvae. First, migratory patterns of TANs appear to be relatively
active when the cells were meandering along the tumor perime-
ter, and become relative motionless in the tumor, while the
migration of NNs in kras larvae are uniformly active regardless
of their locations. Second, Giemsa staining of TANs showed a high
percentage of hyper-segmented nuclei, which is consistent with
the report that pro-tumor N2 neutrophils in mouse models have
hyper-segmented nuclear structure while anti-tumor N1 neu-
trophils have largely round nucleus morphology [4]. Third, by
RT-qPCR analyses, TANs showed downregulation of anti-tumor
genes (e.g., il4, il6, il8, il10, il12, and tnfa) and upregulation of
pro-tumor genes such as il1b, which also promotes early cancer
angiogenesis [35], indicating a potential role of TANs in
pro-angiogenesis in HCC initiation. A complete search for more
critical genes expressed in TANs for promoting early hepatocar-
cinogenesis could be carried out in the future by RNA-Seq analy-
ses in our present model.
In summary, our study suggests that oncogenic krasG12V
expression in hepatocytes favors a pro-inﬂammatory microenvi-
ronment by increased Tgf-b1a expression, which attracts a rapid
recruitment of neutrophils to oncogenic livers. These
liver-inﬁltrated neutrophils have stimulating roles in early hepa-
tocarcinogenesis and they lost anti-tumor activity. Our data are
consistent with the view that the presence of neutrophils in the
tumor microenvironment is an important marker in the aggres-
siveness of the liver cancer progression [46,47]. A high neutrophil
density in the tumor would be an indicator of high hyperplasia
and low apoptosis. Thus, Neutrophils are not bystanders in hep-
atocarcinogenesis and instead they are actively promoting its ini-
tiation and progression.Financial support
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